Mustafa Raoof
- Immunology top 2%
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 22
- Clinical Biochemistry top 2%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 26
- Colorectal Cancer Screening and Detection 11
- Colorectal Cancer Treatments and Studies 10
-
- Intraperitoneal and Appendiceal Malignancies 25
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
-
- Renal cell carcinoma treatment 9
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Carl J. HauserQin ZhangKiyoshi ItagakiYuka SumiKarim BrohiTolga SursalWolfgang G. JungerYu Chen
- Journals
- Nature (1 paper)Journal of Clinical Oncology (10 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- United StatesPolandNetherlands
In The Last Decade
Mustafa Raoof
92 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Immunology 1.3k
- Critical Care and Intensive Care Medicine 234
- Hepatology 303
- Clinical Biochemistry 200
- Oncology 728
Countries citing papers authored by Mustafa Raoof
This map shows the geographic impact of Mustafa Raoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Raoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Raoof more than expected).
Fields of papers citing papers by Mustafa Raoof
This network shows the impact of papers produced by Mustafa Raoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Raoof. The network helps show where Mustafa Raoof may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mustafa Raoof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 21 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 7 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 170 | |
| 17 | 2018 | 10 | |
| 18 | 2018 | 7 | |
| 19 | TOWARD PACLITAXEL-(60)FULLERENE IMMUNOCONJUGATES AS A TARGETED PRODRUG AGAINST CANCER | 2014 | 10 |
| 20 | Incidence of Post General Anesthesia Complications in Recovery Room | 2012 | 7 |
About Mustafa Raoof
Mustafa Raoof is a scholar working on Hepatology, Oncology and Surgery, having authored 104 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (26 papers), Intraperitoneal and Appendiceal Malignancies (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), Colorectal Cancer Screening and Detection (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Renal cell carcinoma treatment (9 papers) and Gastric Cancer Management and Outcomes (9 papers). The work is most often cited by research in Immunology (1.3k citations), Critical Care and Intensive Care Medicine (234 citations) and Hepatology (303 citations). Mustafa Raoof has collaborated with scholars based in United States, Poland and Netherlands. Frequent co-authors include Carl J. Hauser, Qin Zhang, Kiyoshi Itagaki, Yuka Sumi, Karim Brohi, Tolga Sursal, Wolfgang G. Junger, Yu Chen, Yuman Fong and Susanne G. Warner. Their work appears in journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.